AI-Powered Quantification for Myeloma WB-MRI – Publications
Protocol and acquisition
Implementation of Whole-Body MRI (MY-RADS) within the OPTIMUM/MUKnine multi-centre clinical trial for patients with myeloma
Rata, M., Blackledge, M., Scurr, E. et al.
Insights Imaging (2022)
https://doi.org/10.1186/s13244-022-01253-0
Image quality in whole-body MRI using the MY-RADS protocol in a prospective multi-centre multiple myeloma study
Keaveney, S., Dragan, A., Rata, M. et al.
Insights Imaging (2023)
https://doi.org/10.1186/s13244-023-01498-3
An open-source repository-based tool for quality control of imaging protocol compliance: demonstration in a multicentre MRI study
Keaveney, S., McHugh, D. J., Rata M. et al.
British Journal of Radiology (2025)
https://pubmed.ncbi.nlm.nih.gov/40493889/
Image quality of whole-body diffusion MR images comparing deep-learning accelerated and conventional sequences
Ponsiglione, A., McGuire, W., Petralia, G. et al.
Eur Radiol (2024)
https://doi.org/10.1007/s00330-024-10883-5
Myeloma diagnosis and response assessment
Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS)
Messiou, C., Hillengass, J., DelormeS. et al.
Radiology (2019)
https://pubs.rsna.org/doi/10.1148/radiol.2019181949
Comparison of MRI, [ 18 F]FDG-PET/CT, and [ 18 F]FDG-PET/MRI for Initial Staging of Multiple Myeloma : A Systematic Review and Meta-analysis
Tordjman M., Yuce M., Geahchan, A. et al.
Clin Nucl Med. (2025)
https://pubmed.ncbi.nlm.nih.gov/40644586/
Prospective Evaluation of Whole-Body MRI versus FDG PET/CT for Lesion Detection in Participants with Myeloma
Messiou C., Porta N., Sharma B. et al.
Radiol Imaging Cancer (2021)
https://pubmed.ncbi.nlm.nih.gov/34559006/
Whole body MRI by MY-RADS for imaging response assessment in multiple myeloma
Messiou C., Porta N., Koh D.-M. et al.
Blood Cancer J (2025)